Edgewise Therapeutics Files Initial Beneficial Ownership Statement for Director Christopher Nathan Martin
I'm PortAI, I can summarize articles.
Edgewise Therapeutics Inc. has filed an initial statement of beneficial ownership (Form 3) with the U.S. SEC, identifying Christopher Nathan Martin as a beneficial owner in his role as Director. The filing is available via EDGAR. This AI-generated news brief by Public Technologies is for informational purposes only and not financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments